We have recently demonstrated the in vivo release of substance P from the spinal cord of the cat and rat. In the rat, this release can be evoked by the addition of potassium and abolished by the deletion of calcium. In the cat, the release is produced by high but not low intensity stimuli delivered to the sciatic nerve. This release is abolished by the systemic administration of morphine or by the administration of morphine into the spinal perfusate. Antagonism of this release by naloxone has been demonstrated both by systemic and intrathecal administration. The possibility that substance P may serve as a nociceptive transmitter is further supported by the observation that intrathecal capsaicin depletes spinal ,ubstance P and produces a long-term thermal but not mechanical analgesia. Considering the possibility that the ongoing release of substance P might be under a tonic modulation by endogenous enkephalinergic systems, we sought to examine the release of methionine en kephalin from the ventricles and the spinal cord of the cat. In these experiments we were able to demonstrate in preliminary work that sciatic nerve stimulation would produce an enhancement of the levels of methionine en kephalin recovered from both the cerebral ventricles and the spinal cord. Stimulating the sciatic nerve bilaterally at A-fibre intensities produced some increase in the levels of both perfusates. The greatest increase (2-3 fold) was observed following stimulation intensities which recruited the Ad/Cfihre peripheral afferent population. These data offer support for the possibility that peripheral stimulation may in some fashion activate two endogenous enkephalinergic systems, one in the cord and one in the brainstem. The spinal enkephalinergic system could produce some modulation of the sensory input at the level of the first primary afferent synapse by modulating the release of suhstance P in a manner mimicked by the intrathecal administration of e.xogenous opiates. As we have also shown that intracerebral morphine increases the release of serotonin from the spinal cord, we speculate that the release of supraspinal en kephalin may serve as the link between the peripheral sensory environment and the activation of the descending modulation of sensory function.
T. L. Yaksh, Department of Neurosurgical Research and Pharmacology, Mayo Clinic and Foundation, Rochester, Minnesota, U.S.A. We have recently demonstrated the in vivo release of substance P from the spinal cord of the cat and rat. In the rat, this release can be evoked by the addition of potassium and abolished by the deletion of calcium. In the cat, the release is produced by high but not low intensity stimuli delivered to the sciatic nerve. This release is abolished by the systemic administration of morphine or by the administration of morphine into the spinal perfusate. Antagonism of this release by naloxone has been demonstrated both by systemic and intrathecal administration. The possibility that substance P may serve as a nociceptive transmitter is further supported by the observation that intrathecal capsaicin depletes spinal ,ubstance P and produces a long-term thermal but not mechanical analgesia. Considering the possibility that the ongoing release of substance P might be under a tonic modulation by endogenous enkephalinergic systems, we sought to examine the release of methionine en kephalin from the ventricles and the spinal cord of the cat. In these experiments we were able to demonstrate in preliminary work that sciatic nerve stimulation would produce an enhancement of the levels of methionine en kephalin recovered from both the cerebral ventricles and the spinal cord. Stimulating the sciatic nerve bilaterally at A-fibre intensities produced some increase in the levels of both perfusates. The greatest increase (2-3 fold) was observed following stimulation intensities which recruited the Ad/Cfihre peripheral afferent population. These data offer support for the possibility that peripheral stimulation may in some fashion activate two endogenous enkephalinergic systems, one in the cord and one in the brainstem. The spinal enkephalinergic system could produce some modulation of the sensory input at the level of the first primary afferent synapse by modulating the release of suhstance P in a manner mimicked by the intrathecal administration of e.xogenous opiates. As we have also shown that intracerebral morphine increases the release of serotonin from the spinal cord, we speculate that the release of supraspinal en kephalin may serve as the link between the peripheral sensory environment and the activation of the descending modulation of sensory function.
SPINAL CORD MECHANISMS IN THE CONTROL OF PAIN

A. W. Duggan, Department of Pharmacology, Australian National University, Canberra
There is increasing evidence that the transfer of nociceptive information from impulses in primary afferent fibres to ascending spinal tracts can be interrupted in several ways. Nociceptive information is conveyed to the spinal cord in unmyelinated (C) and small myelinated (Ad) fibres which form complex synaptic arrangements mainly in the sub>tantia gelatinosa of the upper dorsal horn. It is this area where inhibition of spinal transmission of nociceptive information probably occurs.
Electrical stimulation of raphe nuclei of the brain stem inhibits the excitation of spinal neurones by noxious skin stimuli. Neurones containing 5-hydroxytryptamine (5HT) occur in the areas stimulated and it has been proposed that release of this amine near spinal neurones mediates the resultant analgesia. Administered in the substantia gelatinosa from micropipettes, 5HT selectively reduces the responses of dorsal horn neurones to noxious skin stimuli. It has not been demonstrated, however, that 5HT antagonists, administered near spinal neurones or in the substantia gelatinosa, reduce the effects of raphe stimulation.
Opiates and enkephalins when administered in the substantia gelatinosa also selectively interrupt the spinal transmission of nociceptive information. This action probably results from an inhibition of transmitter release from the terminals of primary afferent fibres. Enkephalincontaining neurones occur within the substantia gelatinosa, but the physiological role of such a system is as yet unknown.
The contribution of the spinal actions of morphine to analgesia following systemic morphine has been subject to dispute. It has been proposed that a major action of morphine is to activate descending, inhibitory fibres, possibly from the raphe nuclei, and that direct spinal effects are relati\ely unimportant. Recent measurements of descending inhibition of spinal neurones have shm\ n, however, that this is decreased by analgesic doses of morphine. This decreased descending inhibition to some extent nullifies the direct spinal actions of morphine. Analgesia probably results therefore from an action of morphine at several sites in the central nervous system.
PAINFUL NERVE LESIONS Sydney Sunderland, Professor EmerilUS of Experimenlal Neurology, Universily of Melbourne
Nerve lesions range from those at one end of the spectrum that are painless to those which are accompanied by spontaneous unrelenting pain of incapacitating severity which is causalgia with, in between, a variety of lesions which may, in one way or another, be painful.
Two interesting questions emerge from a study of these phenomena. What is the pathophysiological basis of the painful nerve lesion and in what respects does it differ from the painless lesion? What pathophysiological mechanisms are responsible for the pain itself. For such mechanisms are not necessarily confined to the affected segment of the nerve but could shift to the peripheral tissues or centrally to the neuraxis.
A study of some common painful nerve lesions reveals that the pathophysiological basis of the painful state follows no constant pattern.
The pain of the carpal tunnel syndrome is the consequence of an intrafunicular anoxia caused by obstruction to the venous return from the nerve funiculi as the result of increased pressure in the carpal tunnel.
The pain due to spinal nerve involvement in cervical spondylosis is not caused by nerve compression but by nerve friction over bony irregularities leading to fibrosis, the formation of restrictive adhesions which lower the threshold at which traction begins to produce harmful effects on nerve fibres, fibrosis, ischaemia and the chronic irritation of traumatised nerve fibres. In the lumbar region, however, a compression factor contributes to spinal nerve pathology while bony irregularities about the foramen would, if present, also damage nerve fibres by friction.
Focal and generalised neuropathies vary considerably in the extent to which pain may be a feature. On the other hand pain may also be a feature of neuropathies in which there is a loss of myelinated fibres of all sizes. But there is no characteristic pattern of fibre loss in painful neuropathies.
The pain from painful neuromas is attributed to the deformation and irritation of unduly hypersensitive inadequately sheathed fine nerve fibres or free nerve terminals. An abnormal change in the impulse generating properties of fine free nerve terminals initiated by noradrenaline could also be a possible pathogenic factor in causing pain. This explanation, however, fails to explain why some neuromas are exquisitely sensitive and others insensitive even in the same individual where the two may present apparently identical structures.
In causalgia the pain-producing impulses could originate in the peripheral tissues where the pain is felt, in the damaged segment of the nerve or at central levels in the neuraxis. An integrated study of the clinical features of causalgia and the peripheral and central effects of injury to peripheral nerves rejects the "peripheral" hypothesis and confirms that, while the damaged segment of the nerve (hypersensitive nerve terminals, arti ficial synapses and large nerve fibre-fine fibres imbalance) may be the source of the pain in some cases it cannot be the offending focus in others. The most likely mechanism responsible for the spontaneous, persistent, incapacitating pain of immediate onset is based on the retrograde neuronal changes induced by damage to the peripheral and processes of nerve cel". As Anaesthesia and Intensive Care, Vol. VIII, No. 3, August, /980 a result of the nerve injury, the structure and physiological properties of pools of posterior horn neurons become altered in a manner and to a degree which converts them into foci of abnormal activity. These foci, in turn, initiate a chain reaction along sensory transmission pathways as far centrally as the cortex where causalgia becomes the functional expression of the disorderly activity on the sensorium.
Anoxia, ischaemia, mechanical deformation, nerve fibre dissociation, the formation of fine hypersensitive free nerve terminals and artificial synapses in the damaged nerve segment, the direct effect of chemical agents on nerve fibres and the formation of foci and patterns of abnormal neuronal activity within the neuraxis based on the retrograde changes in nerve cells consequent on the nerve injury are all factors which should be taken into consideration when investigating a painful nerve lesion. In the absence of a clear understanding of the genesis of the pain in a particular nerve lesion it becomes difficult to plan and initiate effective therapy. I. Pilowsky, Deparlment of Psychiatry, Royal Adelaide Hospi/al, Adelaide, South Australia Pain is an experience shaped by somatic, psychological and social influences. From a psychiatric point of view, syndromes may be classified into those in which abnormal illness behaviour is present, and those in which it is absent.
PSYCHIATRIC ASPECTS OF PAIN
The latter states include psychophysiological reactions such as are associated with anxiety neuroses and depressive neuroses. In addition, pain in some form may occur with any type of psychiatric illness.
In the case of abnormal illness behaviour (AIB) pain can be prominent and difficult to manage. AIB is defined as a persistence of an inappropriate way of perceiving, evaluating and reacting to one's state of health, despite the fact that a doctor had provided a satisfactory explanation of the situation in a manner comprehensible to the particular patient. AIB presents in psychotic and neurotic forms. In rare cases it is motivated by conscious considerations, but such malingering is rare.
The neurotic forms of AIB can usually be diagnosed as hypochondriacal or conversation reactions, and require to be treated with a multi disciplinary approach.
In treating individual patients, an understanding of the dynamics of the pain state is important. Pain is associated with a sense of threat and a sense of loss. This is associated with anxiety, anger and depression. All of these feelings may be allayed or exacerbated by the doctor's response, and they must be assessed and appropriately managed.
SPLANCHNIC NERVE BLOCK R. A. Boas, V. S. Hatangdi and E. C. Richard, Pain Clinic, Auckland Hospital, Auckland, New Zealand
A trial of splanchnic nerve block in the treatment of upper abdominal malignant pain was prompted by frequent problems encountered in controlling spread of neurolytic solution about tumour or fibrosis in the region of the pancreas. The technique for splanchnic nerve block involved bilateral needle placement into the lower end of the posterior mediastinum where the splanchnic nerves converge and lie within a well confined anatomical compartment prior to piercing the diaphragm. Accurate needle placement is required to achieve safety and control of solution spread and f1uoroscopic X-ray screening a mandatory adjunct 10 this procedure. After correct positioning, neurolytic destruction is achieved with a phenol solution of 10070 in Conray 420 or Renografin 76. Weaker solutions of 7070 gave incomplete destruction of th~ larger nerve bundles. This solution offers radio-opacity for X-ray screening and filming, is free of pain during injection, and uses relatively small non-toxic volumes of 8-\0 ml for compartmental spread on either side. A series of II patients received splanchnic block for pain from carcinoma of the pancreas and in each case relief followed without complication. Five patients had return of pain within two weeks, but none to the extent of requiring repeat injections. This block appears 10 offer benefit, particularly in those patients with pathology or anatomical distortion in the retroperitoneal tissues containing the coeliac plexus.
THE USE OF INTRATHECAL NEUROLYTIC AGENTS
D. B. Gibb, Pain Clinic, Sf. Vincent's Hospital, Sydney
The subarachnoid injection of a neurolytic agent is best reserved for use in the management of intractable pain of malignant origin. Our general objectives in treating conditions of this nature are to keep the patient comfortable, ambulant, at home and on oral medicatiom. only.
Results are usually best where the pain is circumscribed and unilateral, and where the patient has not become addicted 10 narcotic analgesics. It is important 10 consider every patient individually and to weigh the advantages of pain relief against the possible complications of the block in each case.
Intrathecal block can be performed at any spinal level. Complications, however, are most significant at the levels of brachial and lumbosacral outtlow (limb and sphincteric disturbances). Injections inlO these regions should therefore be avoided unless they are justified by the particular circumstances.
Our aim is to block only one spinal nerve on one side with each injection. Widespread pain may require several injections at different levels. The essential aspects of the technique are correct positioning of the patient and the slo\\ injection of small volumes of neurolytic agent.
The principal neurolytic agents used in our clinic are absolute alcohol, which is hypobaric, and 6070 phenol in glycerine, which is hyperbaric. Alcohol has more profound and longer lasting effects than phenol, but is associated with a higher incidence of complications. We reserve phenol for use in midline perineal pain and in situations where minimisation of complications is a prime objective.
It is often difficult to accurately assess the value of a neurolytic block to an individual patient. Assessment should take into account the patient's opinion, anatomical mapping of the denervated area and changes in the patient's mood, drug intake, sleeping pattern, appetite and general activities. Opinions of the patient's friends, relatives and nursing attendants are often invaluable.
INTRATHECAL METHYLPREDNISOLONE IN THE RELIEF OF PAIN FROM THE VERTEBRAL METATASIS
V. S. Hatangdi, P. S. Melding, R. A. Boas and E. G. Richards, Auckland Hospital, Auckland
The technique of intrathecal or epidural injection of long act ing steroid has enjoyed \\ ide popularity in the relief of lumbo-sciatic syndrome of benign aetiology. To date, there is scant information on the value of such methods in the treatment of neuritic pain of metastatic disease in or about the vertebral column. Bernard et al. reported effective analgesia for up to two weeks after intrathecal steroid in one pat ient with sciatic pain secondary 10 a space occupying lesion.
Of the 56 patients treated at the Auckland Pain Clinic for pain of pelvic malignancy, 16 had pain of radicolopathy or neuropathy resulting from vertebral secondaries. Seven patient;, were given intrathecal methylprednisolone, which gave relief from pain for periods ranging from four weeks to three months. Nine others were given epidural steroid with variable duration of pain relief. There were no immediate or long-term untoward effects with this technique and it can be repeated if necessary.
It was suggested that this simple and conservative method should be employed as the first choice of treatment before proceeding to denervating procedures such as surgical or chemical rhizotomy.
"WHAT'S A NICE CLINICAL PHARMACOKINETICIST LIKE ME, DOING IN A PAIN UNIT LIKE THIS?"
L. E. Mather, Deparrment oJ Anaesthesia and Intensive Care, Flinders Medical Centre, Adelaide
Whereas the majority of patient;, having systemic analgesics for chronic pain generally respond predictably and appropriately to conventional dosage regimens, some will not. For such patients there is a dilemma -is the analgesic appropriate for this patient or is the dosage regimen of the analgesic inappropriate? The dilemma cannot be resolved without developing a pharmacokinetic profile on the patient. An intravenous infusion is used to ascertain whether the patient can become pain free at blood concentrations of the analgesic which are tolerably free 0: adverse effects. If analgesia cannot be achieved, it is likely that the analgesic or systemic analgesic therapy in general is inappropriate. If an analgesic blood concentration is found, then a dosage regimen is designed to reliably produce this effect. From serial blood samples taken throughout the infusion period and afterwards, a model is constructed for the disposition of the analgesic in that patient. The model is made of the apparent volumes of distribution (relationship between dose and blood concentration), half lives (how frequently multiple doses should be given) and clearances (how efficiently the body disposes of the drug). These data provide guidelines for designing future therapy and, in themselves, provide clues as to why previous therapy may have been unsuccessful. Having decided that systemic analgesia is appropriate, useful dosage forms and regimens of the analgesic are evaluated from the patient's response.
Using pethidine as a model potent analgesic, investigations in our Unit have shown that oral tablets and rectal ;,uppositories are useful methods of administration. Studic;, in three selected patients illustrate their application to chronic pain therapy.
In patient No. 1, who suffered post-traumatic neuralgia, analgesia was consistently obtained when the pethidine blood concentration 0.3 mg/l was reached -irrespective of the route of administration. Multiple dose oral administration gave blood concentrations in excess of the minimum for analgesia over many hour;,. Bioavailability of oral pethidine was 591110 in this patient, whereas rectal suppositories gave 1001110 bioavailability but slower absorption. In patient No. 2, with long-standing pancreatitis, similar oral and rectal absorption profiles were obtained. In this patient, analgesia was obtained at 0.25 mg/I and was readily produced after mUltiple oral doses.
Patient No. 3 achieved complete pain relief at pethidine blood concentrations in excess of 0.25 mgll. This corresponds to the first 90 minutes after a 100 mg intravenous bolus. Oral or rectal administration of 200 mg resulted in no analgesia at all. Each of these doses resulted in maximum blood concentrations of only 0.1 mg/I, corresponding to only 251110 bioavailability. In contrast, intramuscular injection of pethidine lOO mg produced rapid and complete absorption and provided excellent analgesia.
These three cases have been selected to illustrate the usefulness of pharmacokinetic techniques as an adjunct to the investigation and treatment of patients with chronic pain. Such techniques involve the construction and interpretation of mathematical models of drug blood concentration-time data and their integration with pharmacologic response data. These are but two reasons for finding a clinical pharmacokineticist in a pain unit like this. Studies of pharmacokinetics and analgesic effects have been made after the administration of pethidine into the epidural space.
In seven patients with postoperative pain, preservativefree pethidine hydrochloride, lOO mg in 10 ml physiological saline, was injected via an epidural catheter. Onset of pain relief at five minutes coincided with the presence of relatively high concentrations (0.5-2 mg/I) of pethidine in CSF. Complete pain relief (visual analogue scale) occurred within 12-20 minutes in all patients and corresponded to pethidine CSF concentrations of 10-20 mg/1. Typical peak blood pethidine concentrations occurred after approximately 40 minutes. Mean absorption half-life after epidural administration of pethidine was 25 minutes. Over periods varying from two to four days, doses of pethidine as required gave a mean duration of analgesia of six hours (range 4.5 to 20 hours). In patients with chronic pain, 30 mg pethidine hydrochloride in 6 ml of physiological saline, epidurally as required, provided complete pain relief. Blood concentrations after epidural injections were less than concentrations determined to be analgesic in each patient by prior studies using intravenous infusion of pethidine. The latter level corresponded closely with previously reported analgesic blood concentrations of pethidine (004-0.5 mg/I) determined in post-operative patients. Over a period of one to nine days the mean duration of analgesia was eight hours (range 4.5 to 18 hours). After lOO mg doses, pethidine blood concentrations did eventually approach 'analgesic' levels in some of the patients, approximately 30 to 40 minutes after injection. This resulted in no increase in analgesia and a transitory (10 to 15 minutes) mild sedation. In two patients, intra\cnous injection of naloxone 0.4 mg was followed by immediate reversal of sedation, with no immediate change in level of analgesia. None of the patients with chronic pain obtained complete pain relief with a control injection of saline whereas all obtained complete pain relief with epidural pethidine.
Neurological examination before and after epidural pethidine revealed no detectable change in sensory, motor or sympathetic function. Absence of sympathetic block was confirmed by retention of normal cobalt blue sweat test, while venous occlusion skin plethysmography in the feet showed no evidence of increased blood flow and a normal ice response was retained.
These pharmacokinetic and neurologic data provide strong support for a selective spinal analgesic action of epidural pethidine in man.
ANALGETIC ACTION OF EPIDURAL NARCOTICS IN ANIMALS P. R. Wilson and G. A. Power, Department of Anaesthesia and Intensive Care, Flinders Medical Centre, Adelaide
Narcotic agonists produce dose-dependent naloxonereversible analgesia by a direct action on spinal cord. Systemic opiates act on brainstem and midbrain structures in addition to spinal cord. There is a relationship between analgesia and blood concentration of narcotics in man. It could be expected that narcotics administered into the epidural space of animals would be more effective than equivalent doses given by parenteral routes, but less effective than doses given by intrathecal administration. It could also be expected that analgesia is related to CSF concentration of narcotic, rather than to blood level.
Rats had catheters implanted in lumbar epidural spaces under general anaesthesia. After at least a week for recovery, behavioural effects of epidural and intramuscular narcotics were measured by hotplate testing and expressed as analgetic index. Pethidine was given to groups of four to six rats in doses of 0.5 mg, 1.0 mg and 2.0 mg. Analgetic indices (and SE M) were 2931 (±513), 3263 (±646) and 4584 (± 1031) respectively. Morphine sulphate, 0.1 mg,0.2 mg and 004 mg produced analgetic indices of 2844 (± 370), 5410 (± 1020) and 8389 (± 638) respectively in groups of four to six rats. Intramuscular pethidine 1.0 mg produced an analgetic index of 458 (± 247), and intramuscular morphine 0.2 mg produced an index of 482 (± 99). Analgesia was naloxone-reversible.
Rabbits had catheters implanted in lumbar intrathecal (via cisterna magna) and epidural spaces, and carotid artery. Pethidine was given intravenously or epidurally. Blood and CSF were sampled periodically. Analgesia was measured with a 60°C skin probe. Pethidine 10 mg epidural injection produced an analgetic index of 3681, whereas IV injection produced 385. Pethidine 25 mg epidurally produced an index of 4513; IV 1515. Blood levels of pethidine were lower after epidural administration than IV. Analgesia was significantly higher after epidural administration, supporting the hypothesis.
EFFECTS OF 'PAIN' IMPULSES ENTERING SPINAL CORD THROUGH VENTRAL SPINAL NERVE ROOTS IN SHEEP E. J. Kirk and D. H. Carr, Deparlment oJ Physiology and Anatomy, Massey University, Palmerston North, New Zealand
The present investigation in sheep has confirmed, as originally shown in cats by Coggeshall and others, that a number of small-diameter afferent fibres enter the spinal cord through the ventral roots of spinal nerves. Fifty-seven high-threshold receptors in deep somatic structures (especially those adjacent to the ischium, caudal vertebrae, scapula and humerus) and abdominal and pelvic viscera have produced short (1-2.5 s) bursts of spikes in caudal sacral and cranial thoracic ventral spinal nerve root lets in response to strong mechanical stimuli. A further 35 lowthreshold mechano-receptors (thresholds 1-5 g) had similar (1-2.5 cm') receptive fields and were innervated by fibres conducting at approximately 10 m s -'.
Electrical stimulation of associated peripheral nerves produced a marked decrease in the discharge in motor nerves to the parotid salivary gland (as does noxious stimulation of many somatic and visceral regions). This susceptibility to inhibition of autonomic activity remains after section of corresponding dorsal spinal nerve root lets and provides an index of the reflex effects of afferent impulses in the ventral rootlets. At low intensities of electrical stimulation (1.5 -3 V, 10 s) the duration of the inhibition coincides with the duration of the stimulus. With more intense stimuli (10 V, 30 s) the inhibition usually continues for 120-180 s after the end of the stimulus. Prolonged cessation of salivary motor activity often follows extensive laminectomy, especially in the lumbar region.
It was concluded that afferent impulses entering the spinal cord through ventral spinal nerve roots are likely to have significant effects in central pain mechanisms.
PRESENCE OF AN OEDEMA-INDUCING AGENT IN RAT SPINAL CORD WHICH DIFFERS FROM SUBSTANCE P
Loris A. Chahl and Simon W. Manley, Deparlment oJ Physiology, University oJ Queensland, St. Lucia, Queensland In 1977 Jansco found that treatment of neonatal rats with capsaicin induced selective degeneration of chemosensitive primary sensory neurones and loss of the neurogenic oedema response which occurs on electrical or chemical stimulation of sensory nerves. Jessell showed that acute treatment of rats with capsaicin induced depletion of substance P-like immunoreactivity in the dorsal horn of the spinal cord. The present study was undertaken to determine whether an agent with the same biological activity as substance P could be isolated from rat spinal cords, and further, to determine whether its reduction could be detected in rats pretreated as neonates with capsaicin.
In the first experiments spinal cords were removed from control rats and from rats pretreated with capsaicin (100 mg/kg) on day 2 of life. Supernatants from pooled acidacetone extracts were partitioned with hexane, evaporated and made up in Tris buffered saline. These extracts .... ere then assayed for cutaneous oedema activity in rats by a quantitative Evan's blue dye leakage test. Spinal cord extracts from rats pretreated with capsaicin produced signi ficantly less oedema than those from control rats (0.01 > p > 0.001). On isolated guinea-pig ileum a similar reduction of contractile activity was found in extracts from capsaicin-treated rats. However, when the potency of the extracts was compared with substance P on the two assays, that on guinea-pig ileum was lOoo-fold less than that on the dye leakage test. This indicated that the agent from rat spinal cord was not identical to substance P.
In the second experiment pooled acid-acetone cord extracts obtained from normal rats pretreated with aprotinin ('Trasylol') to prevent bradykinin formation, were partitioned with hcxane and the aqueous phase freeze dried, dissolved in 0.1 M acetic acid and subjected to gelfiltration chromatography on columns of SephadexR G-25 (fine) in 0.1 M acetic acid. Fractions from the columns were freeze dried, redissolved in 5 mM acetic acid, diluted in Tyrode solution and assayed for cutaneous oedema activity and contractile activity on guinea-pig ileum. Results from the dye leakage experiments indicated that there were two peaks of activity in the samples from the columns. One peak was in the molecular size range for peptides and the other was a larger protein, since it was present in the void volume. Assay of the peaks on isolated tissues indicated that the peptide peak had similar pharmacological actions to substance P but the void volume peak did not. Relative potency estimations of guinea-pig ileum and the dye leakage test showed that the peptide peak was not identical to substance P.
These experiments have shown that an oedema-inducing agent, which is partially depleted by capsaicin pretreatment, can be extracted from rat spinal cord. Although the possibility cannot be excluded that other substances present in cord extracts might have affected the relative potency estimations on the assay systems, the experiments indicate that the agent is not identical te' substance P.
INTERACTIONS BETWEEN COLD STRESS AND NARCOTIC ANALGESICS Harris Sehlen and GeoJJrey A. Bentley, Department oJ Pharmacology, Monash University, Clayton, Victoria
It was found that the antinociceptive activity of morphine in mice was potentiated following 15 minutes cold stress (4 QC). However, after 30 minutes exposure, the anti nociceptive potency of morphine returned to control levels and with more prolonged exposure, diminished progressively with time so that after four hours, the previous E. D. 80 of morphine became completely ineffective. Pretreatment with corticosterone 10 mg/kg s.c. resulted in a similar antagonism of the antinociceptive activity of morphine.
Similar studies were conducted on the development of dependence as measured by jumping in response to naloxone challenge (16 mg/kg LP.) following repeated morphine treatment. Mice were treated for four days with twice daily exposure to 4 QC for four hour periods followed each time by a dose of 70 mg/kg morphine. It was found that in comparsion to mice given the same twice daily treatment with morphine at room temperature, the cold stressed animals displayed a considerably enhanced jumping response after naloxone challenge. Similarly, mice pretreated with corticosterone 30 minutes before morphine on the same regimen as above also showed enhanced jumping in response to naloxone although this result was slightly less than seen after cold stress.
It has been reported that increases in 5HT levels enhance the antinociceptive action of morphine. Further, it has been proposed that release of 5HT, following administration of morphine, is necessary for the anti nociceptive action of morphine.
It was shown that neither corticosterone nor cold stress affected the levels of either 5HT or noradrenaline in the brains of mice. It was also found that agents which depleted stores of 5HT in the brain (6FT, pCPA) did not affect the anti nociceptive action of morphine.
These results question the importance of the role played by 5HT in the anti nociceptive action of morphine.
Our results could indicate that cold stress causes a depletion of endogenous opioids through which morphine may produce its effect. Depletion of endogenous opioids has been reported following continuous stimulation. Alternatively, cold stress may produce some conformational change in the morphine receptor, possibly as a result of alterations in sodium ion concentrations.
UNILATERAL KNIFE CUTS PRODUCE IPSILATERAL SUPPRESSION OF PAIN IN THE FORMALIN TEST
George Paxinos, Nancy Amodei and Phil Marks, School of Psychology, University of New South Wales, Sydney, New South Wales
The present experiment investigated the possibility that unilateral brain interventions would produce unilateral deficits in responsiveness to painful stimulation. One hundred and four male rats were subjected to coronal knife cuts in the right or left hemisphere or to control operations. All rats were injected subdermally in the dorsal surface of both forepaws with 0.05 ml of 5070 formalin. Pain reactivity was scored on a four-point scale by rating the spatial position of each injected forepaw relative to the floor. Rats subjected to cuts through (a) the medial forebrain bundle (MFB) and the medial portion of the internal capsule (lC); (b) the thalamus, and (c) through both of these regions, showed greatly reduced pain reactivity of the ipsilateral forepaw. Most of these rats neglected tactile stimuli applied to the contralateral side of the body and turned ipsilaterally in a rotational bowl. Cuts involving the internal capsule and the MFB produced accumulation of substance P-like immunoreactivity in the IC rostral to the cut and accumulation of acetylcholinesterase in the MFB caudal to the cut. A motor deficit cannot be excluded as a factor contributing to the asymmetry observed in the formalin test. However, it is possible that the lower pain reactivity score of the ipsilateral forepaw indicates a disturbance in the neural projections involved in transmission and perception of pain induced by formalin. Acupuncture has been practised in China for several thousand years and forms an important part of Chinese Traditional Medicine particularly in the field of pain relief. Its practice involves insertion of needles into different points in the body according to the condition being treated.
It is not known for certain when and how acupuncture originated. However, it is believed that the earliest needles used were made of stone; such 'stone needles' have been referred to in ancient writings. After stone, needles of bone, bamboo and porcelain made their successive appearance. Finally metal needles came into being, for example, gold and silver. Present day needles are made of stainless steel.
The earliest written reference to acupuncture was in a textbook of medicine called 'Neijin' (Canon of Internal Medicine), probably written between 480 and 221 BC. This was the first systematic account of the practice of acupuncture, and in it the effectiveness of acupuncture in pain relief was stressed.
In AD 256 the first specialised textbook on acupuncture was written by Huang-fu Mi -'The Basic Principles of Acupuncture'. It was based on the 'Neijin', other ancient texts and his own clinical experience. It contained the theory and practice of acupuncture, the positions of 346 acupuncture points and their therapeutic value.
In the Sui Dynasty (AD 581-618) acupuncture was officially recognised as a speciality and teaching courses were set up in the imperial hospital.
In AD 1026 (Sung Dynasty) acupuncturist Wang Wei published his textbook, 'The Bronze Model Illustrated Acupuncture Textbook'. In it he systematised the meridians of acupuncture, ascertained the accuracy of known acupuncture points and added new ones and for the first time in the history of acupuncture texts, there were illustrations. During this period printing became popular and this greatly helped him to spread his knowledge. In AD 1027 he succeeded in casting two life-sized bronze models which were used for teaching and examination purposes.
In AD 1537 and AD 1601 during the Ming Dynasty two important collective works on acupuncture were published.
During the Ching Dynasty, when China was ruled by the Manchus, acupuncture went into decline. In 1822 the government abolished the acupuncture department in the imperial hospital.
After the overthrow of the Manchus in 1911, under the Kuomingtang government, acupuncture did not fare much better. In 1929 this government made an unsuccessful l.A.S.P. attempt to ban Chinese Traditional Medicine (CTM).
With the establishment of the Peoples' Republic of China, CTM (and acupuncture) received a big boost from the government. In 1950 acupuncture research institutes were set up in Peking and other cities, acupuncture was included in the curriculum of medical schools, and there was an upsurge in the publication of acupuncture literature. In 1958 a national campaign was initiated to encourage the study of CTM and to combine Western and CTM. This further stimulated the advance of acupuncture and could be regarded as the watershed of its modern practice in China. On the 30th August 1958, a new dimension was added to acupuncture: in the Shanghai No. I Peoples' Hospital acupuncture anaesthesia (or analgesia) was used successfully for the first time for tonsillectomy with the patient fully awake during the operation. In terms of the conditions for which it is useful and the number of patients treated, acupuncture has never been so extensively practised as in the last 20-odd years.
THE USE OF A PAIN CHART IN THE ASSESSMENT OF DIAGNOSTIC NERVE BLOCKS
J. N. Ditlon, Pain Clinic, Royal Prince Alfred Hospital, Sydney
Diagnostic nerve blocks can be used extensively in the management of chronic pain problems. To obtain optimum results with this technique accurate assessment of the effects of each block must be made. In particular the duration of pain relief and the degree and characteristics of residual pain should be recorded so as to limit errors due to the placebo response, the Injection technique, hospitalisation, changes in drug intake and compound pain patterns.
For this purpose patient pain levels can be recorded on subjective rating scales. We have used a pain chart consisting of a time based 0-10 visual analogue scale on which the patient records pain levels and the site of residual pain at 30 minute intervals. This gives a graph of the patient's response to each diagnostic block which facilitates comparisons between alternative procedures at variable pre-block pain levels.
A series of pain charts was presented to demonstrate different patient responses. These included partial pain relief in extensive pathology, placebo responses and the normal positive response to a diagnostic block. A further series demonstrated different patterns of "complete pain relief" as well as some inappropriate responses and potential errors.
Assessment of the duration of pain relief obtained in 101 procedures when compared to the expected duration of the nerve block demonstrated four different response groups. These were, no pain relief, short duration pain relief, pain relief appropriate to the anaesthetic agent used, and prolonged pain relief. Thus, an immediate "pain relief" response to a diagnostic nerve block can represent a variety of different results, and a technique such as a pain chart must be used to obtain optimal interpretation of each procedure.
